巴西10年卒中患者重症监护入住与结局趋势:COVID-19大流行的影响
该研究基于巴西165个ICU在2011至2020年前瞻性收集的数据,回顾性分析17,115例卒中入院患者(缺血性13,634例、出血性3,481例)的临床特征和10年院内死亡率趋势,并采用可变寿命校正显示(VLAD)和混合效应多因素logistic回归评估2020年大流行的影响。结果显示缺血性卒中院内死亡率低于出血性卒中(9% vs 24%)。2020年VLAD显示COVID-19病例上升伴随死亡率增加,主要见于缺血性卒中。回归模型显示,缺血性卒中患者2020年死亡率高于2019、2018和2017年,尤其见于无意识改变者;出血性卒中患者2020年死亡率升高见于50岁及以下患者(与2019年相比)。作者认为大流行期间卒中入院结局恶化,中断了10年生存率改善趋势,以无昏迷的缺血性卒中和年轻出血性卒中患者受影响最明显。
要点
- 巴西165个ICU 2011–2020年共17,115例卒中入院:缺血性13,634例、出血性3,481例,院内死亡率缺血性9% vs 出血性24%。
- 2020年VLAD显示COVID-19病例上升伴随死亡率增加,主要发生在缺血性卒中之后。
- 混合效应logistic回归显示,缺血性卒中患者2020年死亡率高于2019、2018和2017年,尤其见于无意识改变者。
- 出血性卒中患者2020年死亡率升高见于50岁及以下患者,与2019年相比。
- 作者认为大流行期间卒中入院结局恶化,中断了10年生存率改善趋势,以无昏迷的缺血性卒中和年轻出血性卒中患者为主。
适用人群与场景
- 2011至2020年巴西165个ICU收治的卒中入院患者,共17,115例,其中缺血性卒中13,634例、出血性卒中3,481例。
研究设计与关键结果
- 研究类型:回顾性队列研究,纳入巴西165个ICU在2011至2020年前瞻性收集的数据。
- 共分析17,115例卒中入院,其中缺血性卒中13,634例、出血性卒中3,481例。
- 院内死亡率:缺血性卒中9% vs 出血性卒中24%。
- 2020年各流行病学周VLAD变化显示,COVID-19病例上升伴随死亡率增加,主要发生在缺血性卒中之后。
- 混合效应多因素logistic回归模型显示,缺血性卒中患者2020年死亡率高于2019年、2018年和2017年,尤其见于无意识改变者。
- 出血性卒中患者2020年死亡率升高见于50岁及以下患者,与2019年相比。
证据类型、等级与局限
- 证据类型:回顾性队列研究,数据来自巴西165个ICU前瞻性收集的2011至2020年数据。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,大流行期间卒中入院结局恶化,中断了10年生存率改善趋势;该效应在COVID-19 ICU入院高峰期间更明显,主要影响无昏迷的缺血性卒中患者和年轻出血性卒中患者。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: The coronavirus 2019 (COVID-19) pandemic affected stroke care worldwide. Data from low- and middle-income countries are limited.
RESEARCH QUESTION: What was the impact of the pandemic in ICU admissions and outcomes of patients with stroke, in comparison with trends over the last 10 years?
STUDY DESIGN AND METHODS: Retrospective cohort study including prospectively collected data from 165 ICUs in Brazil between 2011 and 2020. We analyzed clinical characteristics and mortality over a period of 10 years and evaluated the impact of the pandemic on stroke outcomes, using the following approach: analyses of admissions for ischemic and hemorrhagic strokes and trends in in-hospital mortality over 10 years; analysis of variable life-adjusted display (VLAD) during 2020; and a mixed-effects multivariable logistic regression model.
RESULTS: A total of 17,115 stroke admissions were analyzed, from which 13,634 were ischemic and 3,481 were hemorrhagic. In-hospital mortality was lower after ischemic stroke as compared with hemorrhagic (9% vs 24%, respectively). Changes in VLAD across epidemiological weeks of 2020 showed that the rise in COVID-19 cases was accompanied by increased mortality, mainly after ischemic stroke. In logistic regression mixed models, mortality was higher in 2020 compared with 2019, 2018, and 2017 in patients with ischemic stroke, namely, in those without altered mental status. In hemorrhagic stroke, the increased mortality in 2020 was observed in patients 50 years of age or younger, as compared with 2019.
INTERPRETATION: Hospital outcomes of stroke admissions worsened during the COVID-19 pandemic, interrupting a trend of improvements in survival rates over 10 years. This effect was more pronounced during the surge of COVID-19 ICU admissions affecting predominantly patients with ischemic stroke without coma, and young patients with hemorrhagic stroke.
参考来源
- Kurtz P, Bastos LSL, Zampieri FG, et al. Trends in Intensive Care Admissions and Outcomes of Stroke Patients Over 10 Years in Brazil: Impact of the COVID-19 Pandemic. Chest. 2022. PMID: 36347322. doi:10.1016/j.chest.2022.10.033
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。